For: | Cañete R, Escobedo AA, González ME, Almirall P. Randomized clinical study of five days apostrophe therapy with mebendazole compared to quinacrine in the treatment of symptomatic giardiasis in children. World J Gastroenterol 2006; 12(39): 6366-6370 [PMID: 17072963 DOI: 10.3748/wjg.v12.i39.6366] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i39/6366.htm |
Number | Citing Articles |
1 |
R. Cañete, A.A. Escobedo, P. Almirall, M.E. González, K. Brito, S. Cimerman. Mebendazole in parasitic infections other than those caused by soil-transmitted helminths. Transactions of the Royal Society of Tropical Medicine and Hygiene 2009; 103(5): 437 doi: 10.1016/j.trstmh.2008.11.029
|
2 |
E.A. Strand, L.J. Robertson, K. Hanevik, J.O. Alvsvåg, K. Mørch, N. Langeland. Sensitivity of a Giardia antigen test in persistent giardiasis following an extensive outbreak. Clinical Microbiology and Infection 2008; 14(11): 1069 doi: 10.1111/j.1469-0691.2008.02078.x
|
3 |
R. Cañete, A.L. Noda, M. Rodríguez, K. Brito, E. Herrera, P.-E. Kofoed, J. Ursing. 5-Nitroimidazole refractory giardiasis is common in Matanzas, Cuba and effectively treated by secnidazole plus high-dose mebendazole or quinacrine: a prospective observational cohort study. Clinical Microbiology and Infection 2020; 26(8): 1092.e1 doi: 10.1016/j.cmi.2019.12.017
|
4 |
Ana Requena-Méndez, Pilar Goñi, Encarnación Rubio, Diana Pou, Victoria Fumadó, Silvia Lóbez, Edelweiss Aldasoro, Juan Cabezos, Maria Eugenia Valls, Begoña Treviño, Antonio Federico Martínez Montseny, Antonio Clavel, Joaquim Gascon, José Muñoz. The Use of Quinacrine in Nitroimidazole-resistant Giardia Duodenalis: An Old Drug for an Emerging Problem. The Journal of Infectious Diseases 2017; 215(6): 946 doi: 10.1093/infdis/jix066
|
5 |
Roberto Cañete. Mebendazole Is a Potential Alternative in the Treatment of Giardia duodenalis Infection. Current Therapeutic Research 2016; 80: 1 doi: 10.1016/j.curtheres.2016.03.001
|
6 |
Tanja E. Peters, Benno Kreuels, Marylyn M. Addo, Egbert Tannich, Camilla Rothe. Risk factors for and management of metronidazole-refractory giardiasis in international travellers: A retrospective analysis. Travel Medicine and Infectious Disease 2021; 43: 102090 doi: 10.1016/j.tmaid.2021.102090
|
7 |
Roberto Cañete, Katia Brito, Inara Brito, Abel Semper, Maria Elena Gonzalez. Effectiveness and Tolerability of 3-Day Mebendazole Treatment of Giardia duodenalis Infection in Adults and Children: Two Prospective, Open-Label Phase IV Trials. Current Therapeutic Research 2018; 89: 43 doi: 10.1016/j.curtheres.2018.11.002
|
8 |
Roberto Cañete, Pablo Rodríguez, Lumey Mesa, Katia Brito, Ada Prior, Dirce Guilhem, M.R.C.G. Novaes. Albendazole versus metronidazole in the treatment of adult giardiasis: a randomized, double-blind, clinical trial. Current Medical Research and Opinion 2012; 28(1): 149 doi: 10.1185/03007995.2011.637915
|
9 |
Xiaohong Fu, Bo Xiong, Min Zhao, Weifeng Wan, Shaofu Zhang, Xuedong Wu, Jianguo Xu. Quinacrine is active in preclinical models of glioblastoma through suppressing angiogenesis, inducing oxidative stress and activating AMPK. Toxicology in Vitro 2022; 83: 105420 doi: 10.1016/j.tiv.2022.105420
|
10 |
Angel A. Escobedo, Pedro Almirall, Eduardo González-Fraile, Javier Ballesteros. Efficacy of mebendazole in paediatric patients with giardiasis: A systematic review and meta-analysis. Acta Tropica 2018; 188: 50 doi: 10.1016/j.actatropica.2018.08.001
|
11 |
José M Ordóñez-Mena, Noel D McCarthy, Thomas R Fanshawe. Comparative efficacy of drugs for treating giardiasis: a systematic update of the literature and network meta-analysis of randomized clinical trials. Journal of Antimicrobial Chemotherapy 2018; 73(3): 596 doi: 10.1093/jac/dkx430
|
12 |
David R. Hill, Theodore E. Nash. Tropical Infectious Diseases: Principles, Pathogens and Practice. 2011; : 623 doi: 10.1016/B978-0-7020-3935-5.00093-8
|
13 |
E. Chandy, J. McCarthy. Evidence behind the WHO Guidelines: Hospital Care for Children: What is the most appropriate treatment for giardiasis?. Journal of Tropical Pediatrics 2007; 55(1): 5 doi: 10.1093/tropej/fmn073
|
14 |
Raúl Argüello-García, David Leitsch, Tina Skinner-Adams, M. Guadalupe Ortega-Pierres. Giardia and Giardiasis, Part B. Advances in Parasitology 2020; 107: 201 doi: 10.1016/bs.apar.2019.11.003
|
15 |
Derek B. Oien, Christopher L. Pathoulas, Upasana Ray, Prabhu Thirusangu, Eleftheria Kalogera, Viji Shridhar. Repurposing quinacrine for treatment-refractory cancer. Seminars in Cancer Biology 2021; 68: 21 doi: 10.1016/j.semcancer.2019.09.021
|
16 |
Rumana Ahmad, Tahmeena Khan, Bilal Ahmad, Aparna Misra, Anil K. Balapure. Neurocysticercosis: a review on status in India, management, and current therapeutic interventions. Parasitology Research 2017; 116(1): 21 doi: 10.1007/s00436-016-5278-9
|
17 |
DAVID R. HILL, THEODORE E. NASH. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 2010; : 3527 doi: 10.1016/B978-0-443-06839-3.00280-0
|
18 |
David Leitsch. Drug Resistance in the Microaerophilic Parasite Giardia lamblia. Current Tropical Medicine Reports 2015; 2(3): 128 doi: 10.1007/s40475-015-0051-1
|
19 |
Muhammad Usman, Mohammad Siddiq. Probing the micellar properties of Quinacrine 2HCl and its binding with surfactants and Human Serum Albumin. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2013; 113: 182 doi: 10.1016/j.saa.2013.04.089
|
20 |
Angel A Escobedo, Sergio Cimerman. Giardiasis: a pharmacotherapy review. Expert Opinion on Pharmacotherapy 2007; 8(12): 1885 doi: 10.1517/14656566.8.12.1885
|
21 |
M.F. Ara-Montojo, J. Bustamante, T. Sainz, S. Pérez, B. Jiménez-Moreno, G. Ruiz-Carrascoso, P. Rodríguez-Molino, J. Villota, M. García-López-Hortenano, M.J. Mellado-Peña. Intestinal giardiasis in children: Five years’ experience in a reference unit. Travel Medicine and Infectious Disease 2021; 42: 102082 doi: 10.1016/j.tmaid.2021.102082
|
22 |
A A Escobedo, P Almirall, M Alfonso, Y Salazar, I Ávila, S Cimerman, F A Núñez, I V Dawkins. Hospitalization of Cuban children for giardiasis: a retrospective study in a paediatric hospital in Havana. Annals of Tropical Medicine & Parasitology 2011; 105(1): 47 doi: 10.1179/136485911X12899838413420
|
23 |
Kristine Mørch, Kurt Hanevik. Giardiasis treatment: an update with a focus on refractory disease. Current Opinion in Infectious Diseases 2020; 33(5): 355 doi: 10.1097/QCO.0000000000000668
|
24 |
Faiqa Mudassar, Han Shen, Geraldine O’Neill, Eric Hau. Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas. Journal of Experimental & Clinical Cancer Research 2020; 39(1) doi: 10.1186/s13046-020-01724-6
|
25 |
Pedro Almirall, Angel A. Escobedo, Idalia Ayala, Maydel Alfonso, Yohana Salazar, Roberto Cañete, Sergio Cimerman, Martha Galloso, Ilmaems Olivero, Maytee Robaina, Karen Tornés. Mebendazole Compared with Secnidazole in the Treatment of Adult Giardiasis: A Randomised, No-Inferiority, Open Clinical Trial. Journal of Parasitology Research 2011; 2011: 1 doi: 10.1155/2011/636857
|